Reduced facial expressivity (hypomimia) is an early motor feature of Parkinson’s disease (PD), yet its assessment still relies on subjective, coarse-grained clinical scales. Using ExpressionTracker, a consumer-grade application built on Apple’s ARKit framework, we derived 261 facial expression features during standardi...
B. Koyak, Timo Menzel, M. Rodemann et al.· npj Parkinson's Disease· 0 citations
The results suggest that TnT and sNfL capture different dimensions of disease status within the D50 framework, and further longitudinal studies are needed to determine whether combining these biomarkers improves disease stratification or prognostic assessment in clinical practice and therapeutic trials.
Julia Sellin, Sofia Waldorf, Janina von der Gablentz et al.· Annals of Clinical and Trans...· 0 citations
The NULISA multiplex platform supports the use of a multiplexed panel of diverse, inflammatory, glial, and neurodegeneration-associated biomarkers as a complementary diagnostic and prognostic tool alongside established measurements of neurofilaments.
Karthik Baskar, Christina Steffke, S. Bernsen et al.· Neurology(R) neuroimmunology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.